# Dry Eye: Developing Drugs for Treatment Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/dry-eye-developing-drugs-for-treatment-guidance-for-industry/c72442af-b5f2-4a62-88b5-4261f9399657

> FDA guidance document: Dry Eye: Developing Drugs for Treatment Guidance for Industry. Issue date: December 16, 2020. Get complete insights and analysis.

---

## Details

- Title: Dry Eye: Developing Drugs for Treatment Guidance for Industry
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2020-12-16
- Comment Close Date: 2021-03-17
- Last Changed: 2020-12-18
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2020-D-2214">FDA-2020-D-2214</a>

## Related Documents

- [Erosive Esophagitis: Developing Drugs for Treatment: Draft Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/erosive-esophagitis-developing-drugs-for-treatment-draft-guidance-for-industry/db47ebb5-eadc-4f7b-a236-ac6b016c3ec7)
- [Erosive Esophagitis: Developing Drugs for Treatment](https://www.globalkeysolutions.net/guidances/guidance-document/erosive-esophagitis-developing-drugs-for-treatment/985e94e3-4616-49e9-822e-0854256bb10e)
- [Clinical Pharmacology Considerations for Peptide Drug Products](https://www.globalkeysolutions.net/guidances/guidance-document/clinical-pharmacology-considerations-for-peptide-drug-products/1609c8ed-4d50-4235-8a00-9c63176affe8)